Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HURA stock hub

TuHURA Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HURAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

151.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

HURA

In the news

Latest news · HURA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-169.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-96.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HURA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

USD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001498382
Company name	TuHURA Biosciences, Inc.
Country	United States
Country code	US
Employees	22
Employees Change	3%
Employees Change Percent	15.79
Enterprise value	$148.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US8989201038
Last refreshed	2026-05-10
Market cap	$151.3M
Market cap category	Micro-Cap
Price	$2.38
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	HURA
Website	https://www.tuhurabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.87%
FCF yield	-18.31%
P/B ratio	6.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-30.1M
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-74.27
ROCE	-131.2
ROE	-169.2
ROIC	-96.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-37.39%
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$27.4M
Cash	$3.6M
Current Assets	$4.6M
Current Liabilities	$5.9M
Debt	$700,022
Debt Equity	$0.03
Equity	$20.9M
Interest Coverage	-44.97
Liabilities	$6.4M
Long Term Assets	$22.7M
Long Term Liabilities	$501,546
Net Cash	$2.9M
Net Cash By Market Cap	$1.93
Net Cash Growth	-76.56%
Net Debt Equity	$-0.14
Tangible Book Value	$9.9M
Tangible Book Value Per Share	$0.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.78
Net Working Capital	$-4.5M
Quick ratio	0.72
Working Capital	$-1.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-156.81%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-37.37%
200-day SMA	1.94
50-day SMA	2.09
50-day SMA vs 200-day SMA	50over200
All Time High	7.93
All Time High Change	-69.99%
All Time High Date	2024-10-18
All Time Low	0.41
All Time Low Change	480.49%
All Time Low Date	2026-02-03
ATR	0.25
Beta1y	1.78
Beta2y	1.26
Ch YTD	214.5
High	2.43
High52	4.2
High52 Date	2025-05-13
High52ch	-43.33%
Low	2.28
Low52	0.41
Low52 Date	2026-02-03
Low52ch	480.49%
Ma50ch	13.88%
Premarket Change Percent	2.85
Premarket Price	$2.47
Premarket Volume	4,549
Price vs 200-day SMA	22.62%
RSI	52.83
RSI Monthly	37.51
RSI Weekly	56.67
Sharpe ratio	0.25x
Sortino ratio	0.5
Total Return	-156.81%
Tr YTD	214.5
Tr1m	61.36%
Tr1w	2.15%
Tr3m	278.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$10
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.11
Operating Income	$-28.1M
Price target	$9.5
Price Target Change	$299
Price Target Change Top	$320

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,336,726%
Float Percent	55.58%
Net Borrowing	616,976
Shares Insiders	43.01%
Shares Institutions	10.48%
Shares Out	63,578,528
Shares Qo Q	4.61%
Shares Yo Y	156.81%
Short Float	23.54%
Short Ratio	7.03
Short Shares	13.08

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-34.1M
Average Volume	1,234,564.2x
Bv Per Share	0.35
CAPEX	$-76,083
Ch1m	61.36
Ch1w	2.15
Ch1y	-37.37
Ch3m	278.4
Ch6m	-5.56
Change	-0.83%
Change From Open	-1.65
Close	2.4
Days Gap	0.83
Depreciation Amortization	71,265
Dollar Volume	1,166,964
Earnings Date	2026-05-15
Earnings Time	bmo
EBIT	$-28.1M
EBITDA	$-28M
EPS	$-0.63
F Score	1
FCF	$-27.7M
FCF EV Yield	-18.67x
FCF Per Share	$-0.44
Financing CF	19,927,282
Fiscal Year End	December
Founded	2,009
Goodwill	10,738,082
Investing CF	-1,335,361
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-01
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-31
Ma150	1.7
Ma150ch	40.08%
Ma20	2.54
Ma20ch	-6.11%
Net CF	-9,037,229
Next Earnings Date	2026-05-22
Open	2.42
Optionable	No
Position In Range	66.67
Post Close	2.38
Postmarket Change Percent	-1.68
Postmarket Price	$2.34
Ppne	685,169
Pre Close	2.4
Price Date	2026-05-08
Ptbv Ratio	15.26
Relative Volume	0.4x
Share Based Comp	6,424,730
Tr6m	-5.56%
Us State	Florida
Volume	490,321

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HURA pay a dividend?

Capital-return profile for this ticker.

Performance

HURA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HURA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.5%

Float: +55.6% of shares outstanding

Insider ownership

+43.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

HURA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.8

Neutral momentum band

Price vs 200-day MA

+22.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HURA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HURA stock rating?

TuHURA Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HURA analysis?

The full report lives at /stocks/HURA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HURA?

The latest report frames HURA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HURA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.